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ABSTRACT 
Following a request of the European Commission, the European Food Safety Authority (EFSA) evaluated the 
concerns raised by Bulgaria and the accompanying documentation submitted under Article 34 of Regulation 
(EC) 1829/2003 in support of its request to prohibit the cultivation of the genetically modified maize MON 810 
in the European Union. EFSA concludes that neither the arguments put forward by Bulgaria nor the 
documentation reveal new scientific evidence, in terms of risk to human and animal health or the environment, 
that would support the adoption of an emergency measure on the cultivation of maize MON 810 under Article 34 
of Regulation (EC) 1829/2003. In the absence of new relevant scientific evidence, EFSA concludes that its 
previous risk assessment conclusions and risk management recommendations on maize MON 810 and those of 
its GMO Panel remain valid and applicable. 
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SUMMARY 
Upon request of the European Commission, the European Food Safety Authority (EFSA) evaluated 
the concerns raised by Bulgaria and the accompanying documentation submitted under Article 34 of 
Regulation (EC) 1829/2003
3
 in support of its request to prohibit the cultivation of the genetically 
modified (GM) maize MON 810 in the European Union.  
EFSA did not identify new arguments related to maize MON 810 or the Cry1Ab protein that reveal 
new scientific evidence in terms of risk to human and animal health or the environment. In addition, 
EFSA did not further consider the peer-reviewed publications, referred to by Bulgaria, that were 
previously addressed in its scientific outputs on maize MON 810 or related Bt maize events expressing 
Cry1Ab protein, or those of its GMO Panel.  
For completeness of the evaluation, EFSA considered the proceedings abstract by Büchs et al. (2004) 
referred to in the report submitted by Bulgaria. However, due to limitations of the publication format 
and in the absence of sufficient information on the experimental design of the study and data 
generation and analysis, EFSA could not draw any conclusions on the reliability and relevance of this 
abstract for the present evaluation nor for the risk assessment of maize MON 810 in general. Therefore 
EFSA strongly recommends Member States who invoke safeguard clauses under Directive 
2001/18/EC
4
 or emergency measures under Regulation (EC) No 1829/2003 to supply relevant new 
scientific data of a quality which can be subjected to detailed scientific scrutiny.  
EFSA therefore concludes that neither the arguments put forward by Bulgaria nor the supporting 
documentation reveal new scientific evidence, in terms of risk to human and animal health or the 
environment, that would support the adoption of an emergency measure on the cultivation of maize 
MON 810 under Article 34 of Regulation (EC) 1829/2003. In the absence of new relevant scientific 
evidence, EFSA concludes that its previous risk assessment conclusions and risk management 
recommendations on maize MON 810 and those of its GMO Panel remain valid and applicable. 
 
                                                     
3 Regulation No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified 
food and feed. OJ L 268, 18.10.2003, p. 1-23. 
4 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 17.04.2001, p. 1-
39. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION AND EFSA 
The marketing of maize MON 810 (notification C/F/95/12-02) was authorised under Directive 
90/220/EEC
5
 in the European Union (EU) for all, other than food, uses by the Commission Decision 
98/294/EC
6
 of 22 April 1998. Consent was granted to the applicant (Monsanto Europe S.A.) by France 
on 3 August 1998. Food uses of maize derivatives were notified according to Article 5 of the Novel 
Food Regulation (EC) No 258/97
7
 on 6 February 1998.  
On 15 June 2009, the Scientific Panel on Genetically Modified Organisms of the European Food 
Safety Authority (hereafter referred to as EFSA GMO Panel) issued a scientific opinion on the 
renewal of the authorisation for the continued marketing of: (1) existing food and food ingredients 
produced from maize MON 810; (2) feed consisting of and/or containing maize MON 810, including 
the use of seed for cultivation; and (3) food and feed additives, and feed materials produced from 
maize MON 810. The EFSA GMO Panel concluded that “maize MON 810 is as safe as its 
conventional counterpart with respect to potential effects on human and animal health”, and that 
“maize MON 810 is unlikely to have any adverse effect on the environment in the context of its 
intended uses, especially if appropriate management measures are put in place in order to mitigate 
possible exposure of non-target (NT) Lepidoptera”. The EFSA GMO Panel recommended that 
“especially in areas of abundance of non-target Lepidoptera populations, the adoption of the 
cultivation of maize MON 810 be accompanied by management measures in order to mitigate the 
possible exposure of these species to maize MON 810 pollen”. In addition, the EFSA GMO Panel 
advised that “resistance management strategies continue to be employed and that the evolution of 
resistance in lepidopteran target pests continues to be monitored, in order to detect potential changes 
in resistance levels in pest populations” (EFSA, 2009).  
On 30 November 2011, the EFSA GMO Panel adopted a statement supplementing the environmental 
risk assessment conclusions and risk management recommendations on maize Bt11 cultivation (EFSA 
Panel on Genetically Modified Organisms, 2011b). In its statement, the EFSA GMO Panel concluded 
that “subject to appropriate management measures, maize Bt11 cultivation is unlikely to raise 
additional safety concerns for the environment compared to conventional maize” (EFSA Panel on 
Genetically Modified Organisms, 2011b). The EFSA GMO Panel considered that the environmental 
risk assessment conclusions and risk management recommendations on non-target Lepidoptera for 
maize Bt11 apply equally to maize MON 810 due to the similarities between both Bt maize events 
(i.e., identity of amino acid sequence of the core of the Cry1Ab protein, similar biological activity 
against susceptible Lepidoptera, similar Cry1Ab protein expression level in pollen).  
The EFSA GMO Panel further supplemented its previous risk management recommendations on 
maize Bt11 and MON 810 cultivation by reapplying the mathematical model developed by Perry et al. 
(2010, 2011, 2012), in order to consider additional hypothetical agricultural conditions, and to provide 
additional information on the factors affecting the insect resistance management (IRM) strategy 
(EFSA Panel on Genetically Modified Organisms, 2012d).  
On 6 December 2012, following a request from the European Commission, the EFSA GMO Panel 
compiled its previous risk assessment conclusions and risk management recommendations on maize 
MON 810, and considered their validity in the light of new relevant scientific publications published 
from 2009 onwards (EFSA Panel on Genetically Modified Organisms, 2012e). Based on the 
performed literature search, the EFSA GMO Panel concluded that “its previous risk assessment 
conclusions on maize MON 810 as well as its recommendations on risk management measures and 
monitoring remain valid and applicable.”  
                                                     
5 Council Directive 90/220/EEC of 23 April 1990 on the deliberate release into the environment of genetically modified 
organisms. OJ L 117, 8.5.1990, p. 15-27. 
6 Commission Decision of 22 April 1998 concerning the placing on the market of genetically modified maize (Zea mays L. 
line MON810), pursuant to Council Directive 90/220/EEC (98/294/EC). OJ L 131, 5.5.1998, p. 32-33. 
7 Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and 
novel food ingredients. OJ L 43, 14.2.1997, p. 1-9. 
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Following requests of the European Commission to assess the annual post-market environmental 
monitoring (PMEM) reports on maize MON 810 cultivation submitted by the applicant, the EFSA 
GMO Panel issued scientific opinions on the 2009, 2010, 2011 and 2012 PMEM reports on maize 
MON 810 (EFSA Panel on Genetically Modified Organisms, 2011a, 2012a, 2013c, 2014). The EFSA 
GMO Panel noted shortcomings in the methodology for case-specific monitoring and general 
surveillance, and made recommendations to strengthen the annual PMEM activities on the GM maize. 
So far, the data submitted by the applicant in its PMEM reports did not indicate any adverse effects on 
human and animal health or the environment arising from the cultivation of maize MON 810.  
Several EU Member States invoked safeguard clauses or emergency measures to provisionally restrict 
or prohibit the marketing of maize MON 810 on their territory. EFSA or its GMO Panel has been 
asked by the European Commission to evaluate whether the invocation was justifiable on the basis of 
the scientific information submitted in support of a safeguard clause or emergency measure. For all 
cases, EFSA or its GMO Panel concluded that, in terms of risk to human and animal health and the 
environment, no new scientific evidence had been presented that would invalidate its previous risk 
assessment conclusions on maize MON 810 (EFSA, 2004, 2005, 2006a, b, 2008a, b, c, d, 2014a, b; 
EFSA Panel on Genetically Modified Organisms, 2012b, c, 2013a, b, 2014).  
In April 2014, Bulgaria notified to the European Commission the need to take emergency measures 
under Article 34 of Regulation (EC) 1829/2003
8
 but at that time did not provide any scientific 
evidence to support the proposed measures prohibiting the cultivation of maize MON 810. 
In July 2014, Bulgaria notified to the European Commission its analytical report justifying the 
implementation Decision No 431/26.06.2014 of the Council of Ministers of Republic of Bulgaria 
prohibiting the cultivation of maize MON 810 on the territory of Bulgaria. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
EFSA is requested, in accordance with Article 31 of Regulation (EC) 178/2002,
9
 to provide a 
statement:  
1. assessing if the Bulgarian authorities have submitted new scientific evidence in support of 
their request for a prohibition of GM maize MON 810 cultivation according to Article 34 of 
Regulation (EC) 1829/2003, and, where appropriate, 
2. indicating whether this new scientific evidence might lead the GMO Panel to reconsider its 
previous safety assessments of GM maize MON 810. 
CONTEXT OF THE SCIENTIFIC OUTPUT 
The legislative framework regulating GMOs in the EU gives Member States the possibility to 
temporarily restrict the placing on the market of a GMO or its derived food and feed products on their 
territory or in the EU subject to indications of a clear and serious risk to the human and animal health 
or the environment. Member States invoking the so called ‘safeguard clauses’ under Article 23 of 
Directive 2001/18/EC or ‘emergency measures’ under Article 34 of Regulation (EC) 1829/2003 must 
justify their claims with new or additional scientific evidence that was made available after the consent 
for placing on the market of the GMO or its derived food and feed products was granted.  
In this statement, EFSA evaluates, upon request of the European Commission, whether the 
documentation (a report and its complete list of references) submitted by Bulgaria justifies or 
invalidates its request to prohibit the cultivation of maize MON 810.  
                                                     
8 Regulation No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified 
food and feed. OJ L 268, 18.10.2003, p. 1-23.  
9 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety. OJ L 31, 1.2.2002, p. 1-24. 
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EFSA considers the concerns put forward by Bulgaria in the light of recent and relevant scientific 
publications. Concerns of Bulgaria related to co-existence and socio-economic aspects as well as 
regulatory- and policy-related documents listed in the report provided by Bulgaria are not considered 
in this statement as they fall outside the remit of EFSA and its GMO Panel. 
EVALUATION 
At the request of the European Commission, EFSA evaluated the concerns raised by Bulgaria and the 
accompanying documentation (a report and its complete list of references).  
EFSA points out that the arguments put forward by Bulgaria in the aforementioned report do not 
reveal new scientific evidence in terms of risk to human and animal health or the environment. EFSA 
also notes that the peer-reviewed publications, referred to in the report, were addressed previously by 
EFSA or its GMO Panel in various scientific outputs on maize MON 810 or related Bt maize events 
expressing Cry1Ab protein (EFSA, 2004, 2005, 2006a, b, 2008a, b, c, d, 2014a, b; EFSA Panel on 
Genetically Modified Organisms, 2012b, c, 2013a, b, 2014). These publications are therefore not 
considered further in this statement.  
The list of references cited by Bulgaria also contains a workshop proceedings abstract by Büchs et al. 
(2004). Even though not recently published, the latter was considered by EFSA for completeness of 
the evaluation. However, owing to limitations of the publication format (an abstract) and in the 
absence of sufficient information on the experimental design of the study and data generation and 
analysis, EFSA could not draw any conclusions on the reliability and relevance of this abstract for the 
present evaluation nor for the risk assessment of maize MON 810 in general. In order to facilitate a 
thorough assessment of potential risks and quality appraisal of supplied studies, EFSA strongly 
recommends Member States who invoke safeguard clauses under Directive 2001/18/EC or emergency 
measures under Regulation (EC) No 1829/2003 to provide relevant new scientific data of a quality 
which can be subjected to detailed scientific scrutiny. 
In addition, EFSA is not aware of any literature including recent peer-reviewed publication(s) with 
new relevant and detailed scientific data that would invalidate previous risk assessment conclusions 
and risk management recommendations on maize MON 810 (e.g., EFSA Panel on Genetically 
Modified Organisms, 2011 b, 2012 d, e, 2013 c; EFSA, 2009). 
CONCLUSIONS 
EFSA concludes that neither the arguments put forward by Bulgaria nor the supporting documentation 
reveal new scientific evidence, in terms of risk to human and animal health or the environment, that 
would support the adoption of an emergency measure on the cultivation of maize MON 810 under 
Article 34 of Regulation (EC) 1829/2003. In the absence of new relevant scientific evidence, EFSA 
concludes that its previous risk assessment conclusions and risk management recommendations on 
maize MON 810 and those of its GMO Panel remain valid and applicable. 
DOCUMENTATION PROVIDED TO EFSA 
1. Letter from the European Commission, dated 19 November 2014, to the EFSA Executive Director 
requesting the assessment by EFSA of the scientific elements supporting the request from Bulgaria 
to take emergency measure on the placing on the market of maize MON 810 seeds for cultivation 
purposes in the EU. 
2. Acknowledgement letter, dated 8 December 2014, from the EFSA Executive Director to the 
European Commission. 
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